These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38387717)

  • 1. Inhibition of colon C5a/C5a receptor signalling pathway confers protection against LPS-induced acute kidney injury via gut microbiota-kidney axis.
    Xie RC; Zhang JC; Lin XM; Huang T; Wang YT; Zhang LF; Hong XY; Lin XF; Zheng HJ; Luo Z; Yi LT; Ma JF
    Eur J Pharmacol; 2024 Apr; 969():176425. PubMed ID: 38387717
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Meng Y; Zhao M; Ma Q; Hua Q; Hu J; Zhou Q; Yi H; Zhang Z; Zhang L
    Food Funct; 2024 Jul; 15(15):8030-8042. PubMed ID: 38984966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Synbiotic Alleviates Autoimmune Hepatitis by Modulating the Gut Microbiota-Liver Axis and Inhibiting the Hepatic TLR4/NF-κB/NLRP3 Signaling Pathway.
    Kang Y; Kuang X; Yan H; Ren P; Yang X; Liu H; Liu Q; Yang H; Kang X; Shen X; Tong M; Li L; Wang X; Guo L; Ma J; Zhang F; Fan W
    mSystems; 2023 Apr; 8(2):e0112722. PubMed ID: 36794950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Mediates the Protective Effects of Traditional Chinese Medicine Formula Qiong-Yu-Gao against Cisplatin-Induced Acute Kidney Injury.
    Zou YT; Zhou J; Zhu JH; Wu CY; Shen H; Zhang W; Zhou SS; Xu JD; Mao Q; Zhang YQ; Long F; Li SL
    Microbiol Spectr; 2022 Jun; 10(3):e0075922. PubMed ID: 35481834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota mediates the protective effects of β-hydroxybutyrate against cisplatin-induced acute kidney injury.
    Tian R; Wang X; Tang S; Zhao L; Hao Y; Li R; Zhou X
    Biomed Pharmacother; 2024 Jun; 175():116752. PubMed ID: 38761425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK/Egr-1 pathway.
    Wu Q; Zhao M; Li D; He X; Zang W
    FASEB J; 2023 May; 37(5):e22917. PubMed ID: 37039813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel MAGL Inhibitors Alleviate LPS-Induced Acute Kidney Injury by Inhibiting NLRP3 Inflammatory Vesicles, Modulating Intestinal Flora, Repairing the Intestinal Barrier, and Interfering with Serum Metabolism.
    Xiang H; Wang Y; Yang L; Liu M; Sun C; Gu Y; Yao J
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium humate alleviates LPS-induced intestinal barrier injury by improving intestinal immune function and regulating gut microbiota.
    He Y; Wang D; Liu K; Deng S; Liu Y
    Mol Immunol; 2023 Sep; 161():61-73. PubMed ID: 37499314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention effect of Limosilactobacillus reuteri on acute kidney injury by regulating gut microbiota.
    Yang Z; Ni J; Sun X; Cui Q; Zhang X; Zhang M; Zhu X; Wu Z; Tang C; Zhu J; Mao H; Liu K; Wang C; Xing C; Zhu J
    Microbiol Immunol; 2024 Jul; 68(7):213-223. PubMed ID: 38747013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway.
    Tang J; Xu L; Zeng Y; Gong F
    Int Immunopharmacol; 2021 Feb; 91():107272. PubMed ID: 33360370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
    Li L; Wei T; Liu S; Wang C; Zhao M; Feng Y; Ma L; Lu Y; Fu P; Liu J
    J Cell Mol Med; 2021 Jan; 25(2):960-974. PubMed ID: 33280239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS induces pulp progenitor cell recruitment via complement activation.
    Chmilewsky F; Jeanneau C; Laurent P; About I
    J Dent Res; 2015 Jan; 94(1):166-74. PubMed ID: 25359783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota control acute kidney injury severity by immune modulation.
    Yang J; Kim CJ; Go YS; Lee HY; Kim MG; Oh SW; Cho WY; Im SH; Jo SK
    Kidney Int; 2020 Oct; 98(4):932-946. PubMed ID: 32470493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicory ameliorates hyperuricemia via modulating gut microbiota and alleviating LPS/TLR4 axis in quail.
    Bian M; Wang J; Wang Y; Nie A; Zhu C; Sun Z; Zhou Z; Zhang B
    Biomed Pharmacother; 2020 Nov; 131():110719. PubMed ID: 33152909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the Gut Microbiota in Acute Kidney Injury.
    Kobayashi T; Iwata Y; Nakade Y; Wada T
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34067285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Microbiota in Experimental Acute Kidney Injury.
    Shah N; Rabb H
    Nephron; 2023; 147(1):25-30. PubMed ID: 36195072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress in the role of gut microbiota in acute kidney injury.
    Chen T; Chang C; Hou B; Qiu L; Sun H; Zhu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):385-391. PubMed ID: 38970512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine induces intestinal injury by altering gut microbiota and promoting inflammation in mice.
    Wang LB; Xu LL; Chen LJ; Zhang KK; Zhang QY; Chen YK; Li JH; Liu JL; Wang Q; Xie XL
    Toxicol Appl Pharmacol; 2022 May; 443():116011. PubMed ID: 35390362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.